Our staff

She holds a law degree from the University of Barcelona and a master’s degree in Health Policy, Planning and Financing from the London School of Economics and Political Science and the London School of Hygiene and Tropical Medicine. Her main field of interest is cross border healthcare within the EU and health data protection.
She started getting involved in patient advocacy in 2007. Since then she has collaborated with a number of patient organisations across Europe. She has worked at the leading Institute of Public Law (IDP Barcelona) and the European Commission (DG Health and Consumers). Currently she is also Vice-chair of the Workgroup of European Cancer Patient Advocacy Networks (WECAN) and a member of the Ethics Committee at the Chamber of Physicians of Bavaria, Germany.
Ananda speaks Spanish, German, English, Catalan and French. She is currently based in Munich, Germany.

She holds a bachelor’s degree in journalism from the Complutense University of Madrid and a Master’s degree in Audiovisual Communication from the University Antonio de Nebrija in Madrid.
Ana worked as a journalist on weekly newspapers specialising in health and on consumer health monthly magazines. She has been involved in different patient advocacy groups, first as a volunteer and later on within the communication department. Since 2014, Ana worked as PR and press consultant in the health department of an international PR agency developing communication strategies for the main pharmaceutical companies.
Ana has been involved in producing two books focused on patients with cancer as a co-writer and editorial co-ordinator. She speaks Spanish and English.

She holds a Bachelor’s degree in Government from the London School of Economics and Political Sciences and a Master’s degree in International and European Politics from the University of Edinburgh. She also holds a Diploma in Public Relations from the Chartered Institute for Public Relations. Her main area of interest is health policy, with a specific focus on policies affecting drug development and access in European countries.

Kate previously worked for eight years in the Policy Team at Myeloma UK, where she was involved in influencing a range of policy and reimbursement decisions affecting myeloma patient access to good quality care and effective new drugs. She was involved in a number of patient and public advisory panels in the UK healthcare system, including for the Scottish Medicines Consortium, the drug approval body in Scotland.

She been involved in a wide-range of patient organisation networks, both nationally and internationally – most recently chairing the Blood Cancers Alliance, an information-sharing network of haematological cancer charities in the UK.

Kate currently lives and works in Edinburgh, Scotland.

She holds a degree from the advanced technical college in Ulm, Germany, and has an apprenticeship as an electrical engineering assistant.
Ingrid has broad experience in large, medium-sized and start-up companies. She worked as referent and assistant to Executive Boards. In this role she was responsible, for board-, management- and finance-reporting and controlling. She has proficient expertise in project and programme management and implementation of administrative processes as well as in marketing and public relations.

In the health area she worked for the Innovative Medicines Initiative (IMI) project EUPATI. The European Patients’ Academy. This is a pan-European project implemented as a public-private partnership by a collaborative multi-stakeholder consortium from the pharmaceutical industry, academia, not-for-profit, and patient organisations. As Finance and Reporting Officer she supported the EUPATI Director in preparing reports for IMI and the international consortium members. Financial monitoring, control and analysis were part of her responsibility. Ingrid is based in Munich, Germany.

Previously she has worked in a number of roles within the National Health Service (England), most notably as both Project Manager and Commissioning Manager within Community Services, and Urgent Care. She holds a Bachelors Degree in Business & Psychology from the University of Central Lancashire, England. Since moving to Munich, Germany, she has been employed in Executive-Level Assistance and Project Support for a global financial technology provider.

She holds a Master’s degree in Health Sciences from Duke University along with a certificate and licensure as a Physician Assistant in the United States. She also has a Bachelor’s degree in Biology with a minor in Mathematics. Her main interests include medical education, clinical medicine, and patient advocacy. Prior to joining MPE she worked clinically in New York City as an Internal Medicine Physician Assistant and in South Carolina, USA as a Palliative Medicine Physician Assistant.
Tamika is originally from Connecticut, United States and she is currently based in Munich, Germany.

Katie holds a Bachelor of Arts in Journalism and Mass Communication from the University of North Carolina at Chapel Hill and a Master of Arts from Georgetown University in Liberal Studies with a concentration in International Affairs. Katie has a decade of experience with nonprofit organizations and higher education institutions. Prior to joining MPE, Katie served as the Director of Development at a large New York City nonprofit supporting individuals with developmental disabilities where she oversaw fundraising, grant writing, Board relations, and special events. Her interests include health equity and improving healthcare access for vulnerable populations. Katie is originally from North Carolina, United States and is currently based in Munich, Germany.

Anne-Pierre brings 20 years of experience with a wide range of healthcare stakeholders (charity, patient organisation, governmental agency, consultancy and pharmaceutical industry). Her skills and expertise in health communication, cancer prevention and market access, combined with her personal experience as a leukaemia survivor, give her a unique perspective on patient engagement, advocacy and equal access to adequate care.
Anne-Pierre holds a MSc in Economic Evaluation for Health Technology Assessment from the University of York, a MSc in European Social Policy from the London School of Economics and a Diploma in Political Sciences from the Institut d’Etudes Politiques of Strasbourg. She worked as general delegate and program manager in cancer prevention through nutrition and lifestyle (World Cancer Research Fund & Institut National du Cancer [INCa]) and market access director (Kantar Health, Lundbeck & Sanofi).

Jayne holds a BSc in Psychology, an MSc in Child, Adolescent and Family Mental Health, and a PhD in Health Sciences from the University of Stirling. She is interested in the impact of rare and life threatening conditions and generating evidence to support access to health technologies which improve quality of life for individuals and families.

She previously worked as the Health Services Research Manager at Myeloma UK, as a lecturer in in Psychology at the University of Stirling, and on clinical trials at the University of Glasgow (Neurology) and University College London (Institute of Child Health). She is an honorary research fellow at the University of Stirling. She has published work in the fields of patient preferences, the economic and societal impacts of disease, perceptions of patient reported outcome measures (PROMs), and patient and carer perceptions of clinical neurology trials in stroke.

Jayne has worked closely with patients as part of her previous clinical roles within the NHS and children’s hospices. She has also represented patients on research boards and worked with patient and carer panels on large projects and grants, including the Scottish Government funded Cancer Medicines Outcomes Programme (CMOP) and National Institute of Health Research (NIHR) funded studies.

She lives and works in Edinburgh, Scotland.

Lili holds a bachelor’s and a master’s degree in Molecular and Cellular Biology from the University of Glasgow, Scotland. During her studies, her main area of interest was Immunotherapy and Antibody Engineering.
Lili has experience as a laboratory-based researcher focusing on novel drug design at pharmaceutical companies and in academia. Since moving to Hannover, Germany in 2019, she has worked as a freelance scientific writer, collaborating with the European Patients’ Academy on Therapeutic Innovation (EUPATI) among other organisations. Lili speaks English, Hungarian, conversational German and Japanese.

She holds a PhD in Neuroscience and a Master of Biology and Physiology from Sorbonne University (Paris). She studied brain development during her PhD and then worked on brain cellular diversity as a researcher at the Helmholtz Zentrum München. Early involved in education, she has been leading holiday camps for children for many years and worked in a science museum during her studies to promote science, design exhibitions and lead workshops.
Newly interested in science policy and particularly in the field of health, she trained herself to European policy implementation, clinical data management and industrial pharma management before joining MPE as a medical and scientific officer. She is responsible for the coordination and representation of MPE’s involvement in EU projects, the management of MPE’s medical advisory board, the development of a European myeloma clinical trial database and developing scientific education and information at MPE.
Solène comes from France and currently lives and works in Munich, Germany. She speaks French, English and German.